How the Use of non-Registrational Evidence by Medical Affairs Improves Patient Outcomes
This paper discusses the sources and uses of non-registrational evidence and describes why Medical Affairs is positioned to lead and own the nRE Strategic Plan.
This paper discusses the sources and uses of non-registrational evidence and describes why Medical Affairs is positioned to lead and own the nRE Strategic Plan.
Near the end of Jill Donahue’s family trip to Greece, an unlicensed tour guide, Charis, showed what communication mastery looks like.
This MAPS podcast details potential areas for compliant collaboration by MSLs with key external partners.
MAPS speaks with MyHealthTeams Cofounder and CEO, Eric Peacock, about how health communities can help the biopharmaceutical industry develop new products that truly make a difference in patients’ lives.
This paper addresses the complexities of prioritizing contemporary journal offerings to accomplish article objectives and overall publication planning goals.
This session provides a learning opportunity for our audience by providing background on FDA’s Offices of Minority Health and Health Equity, and Women’s Health
Through generation of Medical Insights, MA enhances its “third pillar” role within the pharmaceutical company and demonstrates value as a key driver in activities directly affecting patient outcomes.
This MAPS podcast details strategic opportunities of compliant collaborations between Field Medical and Marketing Development.
This MAPS podcast details strategic opportunities of compliant collaborations between Field Medical and Marketing.
This position paper is intended outline the roles and responsibilities expected of an MSL and provide clarity on the juxtaposition of MSLs and Sales representatives (SRs) when it comes to scientific exchange versus promotional messaging.